Avalanche Treasury Corporation Class A Common Stock vs Twist Bioscience Corp — how do they compare? Avalanche Treasury Corporation Class A Common Stock trades at $0.34 (market cap $15.33M), while Twist Bioscience Corp trades at $125.49 (market cap $7.72B). The key difference: Twist Bioscience Corp is far larger — about 503.6× Avalanche Treasury Corporation Class A Common Stock's market cap, and Twist Bioscience Corp is trading nearer its 52-week high, Avalanche Treasury Corporation Class A Common Stock nearer its low. Which is the better fit depends on your goals.
| AVAT | TWST | |
|---|---|---|
Market Cap | $15.33M | $7.72B |
Sector | Financials | Health |
52-Week High | $10.75 | $124.88 |
52-Week Low | $0.30 | $24.16 |
Enterprise Value | $15.33M | $7.65B |
Trailing returns across standard periods
Avalanche Treasury Corp operates as a digital asset treasury company focused on holding and managing digital asset investments. The company was founded on September 22, 2025, and is headquartered in New York, NY.
Read more on AVAT →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →